July 6, 2024
Home novel therapies
Investment

Increasing Investment in Research & Development for Innovative Medical & Agricultural Solutions Propels the Growth of the Biotechnology Market; says TNR, The Niche Research

  • July 1, 2024

Global Biotechnology Market to Reach Valuation of US$ US$ 6.98 Tn by 2034; Anticipated to Experience CAGR of 14.3% during 2024 – 2034 Wilmington, Delaware, July 01, 2024 (GLOBE NEWSWIRE) — Biotechnology, the convergence of biology and technology, leverages cellular and biomolecular processes to develop innovative products and solutions that improve health, agriculture, and industrial

Read More
Investors

Spruce Biosciences to Participate in May Investor Conferences

  • May 1, 2024

SOUTH SAN FRANCISCO, Calif., May 01, 2024–(BUSINESS WIRE)–Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need, today announced that Javier Szwarcberg, M.D., M.P.H., Chief Executive Officer, will participate in two upcoming investor conferences taking place in May. The JMP

Read More
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent. View more
Accept
Decline